Shih-Hsien Hsu received a Ph.D. from the National Defense Medical Center, Taipei, Taiwan (1996–2001). Shih-Hsien Hsu has a position as a professor and currently works at the Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University (KMU), Kaohsiung, Taiwan (2017–present), a director of the Master’s Program at the Graduate Institute of Medicine, Kaohsiung Medical University (KMU) (2018–present), and a Voice CEO at the Center of Applied Genomics, Kaohsiung Medical University (KMU) (2019–present). Shih-Hsien Hsu has much experience in development biology, gene transcription and regulation, molecular oncology, and immunotherapy. Shih-Hsien Hsu is an expert referee for the journals Hepatology, Oncogene, Cell Death & Disease, Molecular therapy, Cancers, and Biomedicines.
Shyh-Shin Chiou has a position as a professor and currently works at the Division of Hematology-Oncology, Department of Pediatrics, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan. He received his M.D. from the Kaohsiung Medical College, Kaohsiung, Taiwan, and his Ph.D. from the Graduate Institute of Medical Science, Kaohsiung Medical College, Kaohsiung, Taiwan. He is a member of the National Board of Pediatrics, Taiwan; National Board of Hematology, Taiwan; Taiwan Society of Critical Care Medicine; Taiwan Society of Blood and Marrow Transplantation; National Board of Immunology, Taiwan; and Pediatric Emergency Medicine of Taiwan Pediatric Association. His professional specialties are pediatrics, hematology and oncology, molecular biology, and hematopoietic stem cell transplantation. He has 118 publications with 1707 citations and an h-index of 24 (Scopus, 28 December 2023) in these areas.
